Psych Flashcards

(35 cards)

1
Q

Stimulants

Drug names

A

Methylphenidate
Dextroamphetamine
Methamphetamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stimulants

MOA

A

Inc. catecholamines in synaptic cleft (NE, Dopa).

Also blocks NE/Dopa reuptake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stimulants

Clinical use

A

ADHD, narcolepsy, appetite control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Typical antipsychotics (neuroleptics)
Drug names
(Try to Fly High)
(Cheating Thieves are low)

A

> High potency: Trifluoperazine, Fluphenazine, Haloperidol
Low potency: Chlorpromazine, Thioridazine
(Haloperidol + -azines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Typical antipsychotics

MOA

A

Block D2 receptors in nigrostriatal pathway – inc. cAMP.
(Normally inhibited D2 effects are balanced by excitatory M1 effects – blocked D2 means inc. M1 cholinergic activity).
Highly lipid soluble – stored in fat – slow to be removed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Typical antipsychotics

Clinical use

A

Schizophrenia
Psychosis, Acute mania
Tourette syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Typical antipsychotics

Toxicity (High potency)

A

Neuro SE (Huntington dse, delirium, EPS sx).
EPS sx evolution:
- 4 hr: acute dystonia (muscle spasm, stiffness, oculogyric crisis)
- 4 day: akathisia (restlessness)
- 4 wk: bradykinesia (parkinsonism)
- 4 mo: tardive dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Typical antipsychotics

Toxicity (Low potency)

A

Anticholinergic, antihistamine, a1-blockade effects.

Dry mouth, constipation; sedation; hypotension, possible QT prolonged.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Neuroleptic malignant syndrome

A

Disordered thermoregulation and skeletal muscle metabolism (rigidity, myoglobinuria, autonomic instability, hyperpyrexia).
*Mnem. FEVER: Fever, Encephalopathy, Vitals unstable, Enzymes inc., Rigidity
>Tx: Dantrolene, D2 agonist (bromocriptine).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tardive dyskinesia

A

Stereotypic oral-facial movements due to chronic antipsychotic use.
Lipsmacking, choreoathetoid movements.
Can persist ff. meds discontinuation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Atypical antipsychotics

Drug names

A

Olanzapine, Clozapine, Quetiapine

Risperidone, Aripiprazole, Ziprasidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Atypical antipsychotics

MOA

A

Varied effects on 5HT2-receptors, D-receptors, a-receptors, H1-receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Atypical antipsychotics

Clinical use

A

Schizophrenia.
Bipolar d/o (mood-stabilizing).
OCD, anxiety, depression, mania, Tourette syndrome.
Tx-resistant schizophrenia (clozapine).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atypical antipsychotics

Toxicity

A

Fewer EPS and anticholinergic effects vs. typical antipsychotics.
All may prolong QT interval.
>Clozapine: agranulocytosis, wt. gain, seizures, sialorrhea.
>Olanzapine: wt. gain.
>Risperidone: inc. prolactin (lactation, gynecomastia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lithium

MOA, clinical use

A

May be related to inhibition of phosphoinositol pathway.
Mood stabilizer for bipolar – blocks relapse and acute manic events.
SIADH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lithium

Toxicity

A
Movement (tremor).
Nephrogenic DI (polyuria), Hypothyroidism -- close monitoring of TFT, creatinine.
Pregnancy problems (ebstein anomaly).
CI w/ ACEi -- deplete Na, dec. GFR.
*Tx for lithium toxicity: Thiazide
17
Q

Buspirone

MOA, clinical use

A

Anxiolytic (non-BZ) – not muscle relaxant or anticonvulsant.
Stimulates 5HT1A-receptors.
For generalized anxiety d/o.
*Takes 1-2 wks for effect

18
Q

SSRIs

Drug names

A

Fluoxetine, Paroxetine, Sertraline

Citalopram

19
Q

SSRIs

MOA

A

5HT-specific reuptake inhibitors. Antidepressant.

*Takes 4-8 wks for effect – take BZ during initiation period.

20
Q

SSRIs

Clinical use

A

Depression, Generalized anxiety d/o, panic d/o, OCD, bulimia, social phobias, PTSD

21
Q

SSRIs

Toxicity

A

Sexual dysfunction, GI distress, SIADH

Serotonin syndrome

22
Q

Serotonin syndrome

A

Caused by any drug that inc. 5HT (MAOi, SNRI, TCA) – uncommon in pts taking a single serotonergic drug.
Hyperthermia, confusion, myoclonus, CVS instability, flushing, diarrhea, seizures.
Tx: cyproheptadine (5HT2-receptor antagonist).

23
Q

SNRIs

Drug names

A

Venlafaxine, Duloxetine

24
Q

SNRIs

MOA, clinical use

A

Inhibit 5HT, NE reuptake, antidepressants.
For depression.
>Venlafaxine: GAD, panic d/o, PTSD.
>Duloxetine: diabetic peripheral neuropathy.

25
Tricyclic antidepressants | Drug names
Amitriptyline, Nortriptyline Imipramine, Desipramine, Clomipramine, Amoxapine Doxepin
26
Tricyclic antidepressants | MOA
Block NE, 5HT reuptake
27
Tricyclic antidepressants | Clinical use
Major depression. Peripheral neuropathy, chronic pain. Migraine prophylaxis. OCD (clomipramine).
28
Tricyclic antidepressants | Toxicity
Tri-C's: Convulsions, Coma, Cardiotoxicty (Tx w/ NaHCO3 to prevent arrhythmia). Respi depression, hyperpyrexia Sedation, anticholinergic effects, sexual dysfunction.
29
MAO inhibitors | Drug names
Tranylcypromine, Phenelzine, Isocarboxacid | Selegiline (selective MAO-B inhibitor)
30
MAO inhibitors | MOA
Antidepressant. Irreversible binding of MAO, w/c normally breaks down amine neurotransmitters. Inc. NE, 5HT, Dopa.
31
MAO inhibitors | Clinical use
Atypical depression | Anxiety
32
MAO inhibitors | Toxicity
``` HTN crisis (esp. w/ ingestion of Tyramine, like in wine and cheese). CI w/ SSRI, TCA, St. John's wort, dextromethorphan, meperidine -- prevent Serotonin syndrome. ```
33
Bupropion | Clinical use
NE/Dopa reuptake inhibitor. 1st line for antidepressant w/o causing sexual dysfunction. Also for smoking cessation. May worsen GAD due to stimulating effects.
34
Mirtazapine | Clinical use
Atypical antidepressant. a2-antagonist (inc. NE, 5HT release). Potent 5HT2, 5HT3 receptor antagonist.
35
Trazodone | Clinical use, toxicity
``` Atypical antidepressant. Blocks 5HT2 and a1-adrenergic receptors. For insomnia. High doses needed for antidepressant effects. Toxicity: priapism, sedation, nausea. ```